United States News Beep | NewsBeep.com
  • News Beep
  • Breaking News
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
United States News Beep | NewsBeep.com
United States News Beep | NewsBeep.com
  • News Beep
  • Breaking News
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

Health Care & Hospitals

20 posts
MMedication
Lilly's triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes
Read More

Lilly’s triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes

  • September 30, 2026
In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6…
MMarkets
Nerve Repair and Regeneration Market worth $12.64 billion by 2031
Read More

Nerve Repair and Regeneration Market worth $12.64 billion by 2031

  • September 11, 2026
DELRAY BEACH, Fla., Sept. 11, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Nerve Repair and Regeneration Market is projected…
HHealth care
VELMENI Receives FDA 510(k) Clearance for AI-Powered 3D CBCT Dental Imaging Software
Read More

VELMENI Receives FDA 510(k) Clearance for AI-Powered 3D CBCT Dental Imaging Software

  • July 24, 2026
The FDA clearance, issued under 510(k), expands VELMENI’s dental AI portfolio into three-dimensional cone-beam computed tomography, or CBCT,…
MMedication
Novo Nordisk Introduces Extra Savings for Canadians Who Choose Ozempic®
Read More

Novo Nordisk Introduces Extra Savings for Canadians Who Choose Ozempic®

  • May 26, 2026
MISSISSAUGA, ON, May 26, 2026 /CNW/ – Novo Nordisk Canada is announcing that effective Friday, May 29, 2026,…
HHealth care
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
Read More

Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain

  • May 20, 2026
Acquisition will enhance Medtronic’s Neuromodulation portfolio with temporary peripheral nerve stimulation (PNS) technology, enabling earlier intervention for chronic…
MMedication
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
Read More

Lilly’s Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials

  • May 17, 2026
In ATTAIN-MAINTAIN, participants who transitioned from a maximum tolerated dose (MTD) of Wegovy (semaglutide) to Foundayo maintained all…
HHealth care
Creatv Bio Opens CLIA-Certified Laboratory to Support Oncology Drug Development
Read More

Creatv Bio Opens CLIA-Certified Laboratory to Support Oncology Drug Development

  • May 13, 2026
MONMOUTH JUNCTION, N.J., May 13, 2026 /PRNewswire/ — Creatv Bio, a Division of Creatv MicroTech, Inc. (“Creatv”), a…
NNutrition
Function Acquires SuppCo to Bring Trust and Clarity to Supplements
Read More

Function Acquires SuppCo to Bring Trust and Clarity to Supplements

  • May 12, 2026
Function helps reveal what is happening inside your body. SuppCo brings the same clarity to what you put…
HHealth care
Nervonik Announces $52.5 Million Series B Financing to Advance Peripheral Nerve Stimulation Therapy
Read More

Nervonik Announces $52.5 Million Series B Financing to Advance Peripheral Nerve Stimulation Therapy

  • April 28, 2026
LOS ANGELES, April 27, 2026 /PRNewswire/ — Nervonik, Inc., a clinical-stage medical device company developing next-generation peripheral nerve stimulation…
BBusiness
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
Read More

Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera

  • April 27, 2026
Ajax’s lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with…
HHealth care
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
Read More

Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies

  • April 20, 2026
Kelonia’s lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for…
HHealth care
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
Read More

Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer

  • April 7, 2026
Experienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company…
United States News Beep | NewsBeep.com
www.newsbeep.com